Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Eukedos S.p.A. ( (IT:EUK) ) has shared an update.
Eukedos S.p.A. has approved its 2025 draft separate and consolidated financial statements, reporting a consolidated value of production of €52.9 million, up from €51.6 million a year earlier, driven mainly by the Care Area’s 2.1% revenue growth and steady 80% occupancy. Despite higher EBIT of €5.4 million and improved operating performance in the core care business, consolidated EBITDA slipped to €11.1 million and the group’s net loss widened to €749,000, while net financial debt remained heavy at €128.8 million, indicating ongoing leverage pressures even when excluding IFRS 16 effects, with the parent company continuing to post negative EBITDA and EBIT as it mainly serves group entities.
The most recent analyst rating on (IT:EUK) stock is a Hold with a EUR0.66 price target. To see the full list of analyst forecasts on Eukedos S.p.A. stock, see the IT:EUK Stock Forecast page.
More about Eukedos S.p.A.
Eukedos S.p.A., based in Florence and controlled by La Villa S.p.A., operates in the care sector, managing healthcare and assisted-living facilities. The group’s activities are concentrated in its Care Area, where it generates virtually all of its production value and relies heavily on stable occupancy rates, which remained at around 80% in 2025.
Average Trading Volume: 2,315
Technical Sentiment Signal: Sell
Current Market Cap: €11.33M
For detailed information about EUK stock, go to TipRanks’ Stock Analysis page.